Lal Jagdish MD Fayetteville, NC - 28304

Lal Jagdish MD is categorized under Internal Medicine Doctors in Fayetteville, NC and active since 2002.

Lal Jagdish MD was established in 2002, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Jagdish Lal at the company’s single location by writing to 6977 Nexus Court # 101, Fayetteville, North Carolina NC 28304 or by phoning (910) 864-7933. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Lal Jagdish MD
Contact Person: Jagdish Lal
Address: 6977 Nexus Court # 101, Fayetteville, North Carolina 28304
Phone Number: (910) 864-7933
Website Address: raycondainternalmedicine.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 2002
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Lal Jagdish MD was started in 2002 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Jagdish Lal for inquiries that concern Lal Jagdish MD by calling the company number (910) 864-7933, as your correspondence is most welcome. Additionally, the physical location of the single location of Lal Jagdish MD can be found at the coordinates 35.03501,-79.01407 as well as the street address 6977 Nexus Court # 101 in Fayetteville, North Carolina 28304.

For its online presence, you may visit Lal Jagdish MD’s website at raycondainternalmedicine.com and engage with its social media outlets through on Twitter and on Facebook.